Pharmafile Logo

Peter Impey

- PMLiVE

Iressa blood test nears approval in Europe

Diagnostic for AZ's lung cancer drug is less invasive than current tumour biopsy method

- PMLiVE

PAN appoints account director and account manager

Rosemary Behan and Margaux Chung to join the team

Shire Basingstoke

Shire reaches $56.5m US marketing malpractice settlement

Justice Department agreement covers activities for drugs including Adderall

- PMLiVE

Researchers develop breath test for TB

Inhaled form of isoniazid could show almost instant results

- PMLiVE

PharmaVentures increases its Asia-Pacific presence

Aki von Roy will be based in Auckland, New Zealand

- PMLiVE

Aurora launches marketing and engagement framework

Comms agency aims to help optimise pharma firms optimise their efforts

- PMLiVE

Connected moments: capturing patient experience

Capturing an experience when it occurs can give a more accurate and immediate recall

- PMLiVE

Novartis expands eyecare partnership with NHS

And wins new licence for Lucentis

National Institute for Health and Care Excellence NICE logo

Remicade, Humira and Simponi face NICE knock-back

Draft guidance does not recommend the drugs for ulcerative colitis

- PMLiVE

AZ sets up joint lab with Cancer Research UK

Five-year collaboration will drive charity’s research programmes

- PMLiVE

Gilead will file safer HIV combination before year-end

New version of Stribild is less likely to cause side effects

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links